International Journal of Endocrinology

Copyright © 2015 De-Ye Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. S. R. Cummings and L. J. Melton III, “Epidemiology and outcomes of osteoporotic fractures,” The Lancet, vol. 359, no. 9319, pp. 1761–1767, 2002. View at Publisher · View at Google Scholar · View at Scopus
2. W. H. Harris, “The problem is osteolysis,” Clinical Orthopaedics and Related Research, no. 311, pp. 46–53, 1995. View at Google Scholar · View at Scopus
3. J. E. Dowd, L. J. Schwendeman, W. Macaulay et al., “Aseptic loosening in uncemented total hip arthroplasty in a canine model,” Clinical Orthopaedics and Related Research, no. 319, pp. 106–121, 1995. View at Google Scholar · View at Scopus
4. B. Jobke, P. Milovanovic, M. Amling, and B. Busse, “Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients,” Bone, vol. 6, no. 59, pp. 37–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
5. A. Nehme, G. Maalouf, J.-L. Tricoire, G. Giordano, P. Chiron, and J. Puget, “Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study,” Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur, vol. 89, no. 7, pp. 593–598, 2003. View at Google Scholar · View at Scopus
6. J. K. Lee, C. H. Choi, and C.-N. Kang, “Quantitative computed tomography assessment of bone mineral density after 2 years' oral bisphosphonate treatment in postmenopausal osteoarthritis patients who underwent total knee arthroplasty,” Journal of International Medical Research, vol. 41, no. 3, pp. 878–888, 2013. View at Publisher · View at Google Scholar · View at Scopus
7. O. L. Huk, D. J. Zukor, J. Antoniou, and A. Petit, “Effect of pamidronate on the stimulation of macrophage TNF-α release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis,” Journal of Orthopaedic Research, vol. 21, no. 1, pp. 81–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
8. C. Trevisan, V. Nava, M. Mattavelli, and C. G. Parra, “Bisphosphonate treatment for osteolysis in total hip arthroplasty. A report of four cases,” Clinical Cases in Mineral and Bone Metabolism, vol. 10, no. 1, pp. 61–64, 2013. View at Google Scholar · View at Scopus
9. G.-I. Im, S. A. Qureshi, J. Kenney, H. E. Rubash, and A. S. Shanbhag, “Osteoblast proliferation and maturation by bisphosphonates,” Biomaterials, vol. 25, no. 18, pp. 4105–4115, 2004. View at Publisher · View at Google Scholar · View at Scopus
10. L. I. Plotkin, R. S. Weinstein, A. M. Parfitt, P. K. Roberson, S. C. Manolagas, and T. Bellido, “Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin,” Journal of Clinical Investigation, vol. 104, no. 10, pp. 1363–1374, 1999. View at Publisher · View at Google Scholar · View at Scopus
11. M. Kellinsalmi, H. Mönkkönen, J. Mönkkönen et al., “In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts,” Basic and Clinical Pharmacology and Toxicology, vol. 97, no. 6, pp. 382–391, 2005. View at Publisher · View at Google Scholar · View at Scopus
12. M. A. Gonzalez-Moles and J. V. Bagan-Sebastian, “Alendronate-related oral mucosa ulcerations,” Journal of Oral Pathology and Medicine, vol. 29, no. 10, pp. 514–518, 2000. View at Publisher · View at Google Scholar · View at Scopus
13. P. C. de Groen, D. F. Lubbe, L. J. Hirsch et al., “Esophagitis associated with the use of alendronate,” New England Journal of Medicine, vol. 335, no. 14, pp. 1016–1021, 1996. View at Publisher · View at Google Scholar · View at Scopus
14. T. Calvo-Fernández, J. Parra, M. Fernández-Gutiérrez et al., “Biocompatibility of alendronate-loaded acrylic cement for vertebroplasty,” European Cells and Materials, vol. 20, pp. 260–273, 2010. View at Google Scholar · View at Scopus
15. G. Lewis and S. Janna, “Alendronate in bone cement: fatigue life degraded by liquid, not by powder,” Clinical Orthopaedics and Related Research, no. 445, pp. 233–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
16. T. P. Harrigan, J. A. Kareh, D. O. O'Connor, D. W. Burke, and W. H. Harris, “A finite element study of the initiation of failure of fixation in cemented femoral total hip components,” Journal of Orthopaedic Research, vol. 10, no. 1, pp. 134–144, 1992. View at Publisher · View at Google Scholar · View at Scopus
17. N. Verdonschot and R. Huiskes, “The effects of cement-stem debonding in THA on the long-term failure probability of cement,” Journal of Biomechanics, vol. 30, no. 8, pp. 795–802, 1997. View at Publisher · View at Google Scholar · View at Scopus
18. R. T. Müller and N. Schürmann, “Shear strength of the cement metal interface—an experimental study,” Archives of Orthopaedic and Trauma Surgery, vol. 119, no. 3-4, pp. 133–138, 1999. View at Publisher · View at Google Scholar · View at Scopus
19. H. J. Erli, R. Marx, O. Paar, F. U. Niethard, M. Weber, and D. C. Wirtz, “Surface pretreatments for medical application of adhesion,” BioMedical Engineering Online, vol. 2, article 15, 2003. View at Publisher · View at Google Scholar · View at Scopus
20. J. Graham, M. Ries, and L. Pruitt, “Effect of bone porosity on the mechanical integrity of the bone-cement interface,” The Journal of Bone and Joint Surgery. American Volume, vol. 85, no. 10, pp. 1901–1908, 2003. View at Google Scholar · View at Scopus
21. J. M. Moran, A. S. Greenwald, and M. B. Matejczyk, “Effect of gentamicin on shear and interface strengths of bone cement,” Clinical Orthopaedics and Related Research, vol. 141, pp. 96–101, 1979. View at Google Scholar · View at Scopus